HK Stock MarketDetailed Quotes

06998 GENOR-B

Watchlist
  • 1.600
  • +0.020+1.27%
Market Closed Dec 13 16:08 CST
832.49MMarket Cap-1.45P/E (TTM)

GENOR-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q3)Mar 31, 2020
(FY)Dec 31, 2019
Turnover
--14.47M
----
----
--15.93M
--2.96M
----
----
-20.77%10.33M
----
89.47%13.04M
Operating income
14.47M
15.93M
2.96M
-20.77%10.33M
89.47%13.04M
Cost of sales
---349K
----
----
---983K
---787K
----
----
72.85%-2.6M
----
-75.39%-9.56M
Operating expenses
-349K
-983K
-787K
72.85%-2.6M
-75.39%-9.56M
Gross profit
14.12M
14.95M
2.17M
122.46%7.74M
143.15%3.48M
Selling expenses
----
----
----
15.68%-83.14M
-132.52%-63.05M
---98.6M
---27.12M
----
----
----
Administrative expenses
46.94%-38.55M
6.63%-125.24M
13.59%-72.64M
35.31%-134.13M
28.41%-84.06M
14.12%-207.35M
---117.42M
-170.17%-241.44M
-476.79%-32.79M
-301.02%-89.37M
Research and development expenses
51.20%-109.68M
3.36%-564.28M
23.84%-224.78M
4.71%-583.88M
-8.70%-295.14M
12.04%-612.72M
---271.53M
-58.74%-696.57M
-58.41%-111.44M
-61.63%-438.82M
Impairment and provision
----
---8.92M
----
----
----
----
----
----
----
----
-Other impairment is provision
----
---8.92M
----
----
----
----
----
----
----
----
Special items of operating profit
146.61%4.03M
-466.01%-12.76M
-64.33%1.64M
-94.15%3.49M
-79.03%4.58M
103.02%59.56M
--21.86M
-47,808.42%-1.97B
-8.45%1.44M
-57.58%4.14M
Operating profit
56.02%-130.08M
9.14%-711.2M
32.08%-295.78M
8.89%-782.72M
-10.47%-435.5M
70.41%-859.11M
-394.21M
-457.66%-2.9B
-92.78%-142.79M
-84.20%-520.57M
Financing income
-43.36%11.49M
-34.84%34.74M
-27.48%20.29M
124.68%53.31M
275.64%27.97M
538.73%23.73M
--7.45M
495.35%3.72M
-37.77%201K
-61.00%624K
Financing cost
-1,256.34%-8.98M
65.54%-1.04M
61.67%-662K
90.25%-3.02M
91.25%-1.73M
77.43%-30.93M
---19.73M
-3,613.82%-137M
-69.28%-970K
47.83%-3.69M
Earning before tax
53.81%-127.57M
7.50%-677.5M
32.52%-276.16M
15.45%-732.42M
-0.68%-409.25M
71.47%-866.31M
-406.49M
-479.85%-3.04B
-93.17%-143.56M
-81.77%-523.64M
Tax
14.68%1.28M
12.65%2.28M
-57.59%1.12M
117.17%2.02M
-33.32%2.63M
-83.95%932K
--3.95M
551.63%5.81M
--1.04M
--891K
After-tax profit from continuing operations
54.09%-126.29M
7.55%-675.22M
32.36%-275.04M
15.60%-730.4M
-1.01%-406.62M
71.44%-865.37M
-402.54M
-479.73%-3.03B
-91.77%-142.52M
-81.46%-522.75M
Earning after tax
54.09%-126.29M
7.55%-675.22M
32.36%-275.04M
15.60%-730.4M
-1.01%-406.62M
71.44%-865.37M
-402.54M
-479.73%-3.03B
-91.77%-142.52M
-81.46%-522.75M
Minority profit
-20.16%-590K
-369.23%-854K
50.25%-491K
-21.33%-182K
40.22%-987K
95.59%-150K
---1.65M
-412.35%-3.4M
---552K
---664K
Profit attributable to shareholders
54.22%-125.7M
7.65%-674.36M
32.31%-274.55M
15.60%-730.21M
-1.18%-405.63M
71.42%-865.22M
-400.89M
-479.81%-3.03B
-91.03%-141.97M
-81.23%-522.08M
Basic earnings per share
53.70%-0.25
8.28%-1.33
33.33%-0.54
17.14%-1.45
1.22%-0.81
85.84%-1.75
-0.82
-553.97%-12.36
-88.89%-0.51
-68.75%-1.89
Diluted earnings per share
53.70%-0.25
8.28%-1.33
34.15%-0.54
18.08%-1.45
0.00%-0.82
85.68%-1.77
-0.82
-553.97%-12.36
-88.89%-0.51
-68.75%-1.89
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q3)Mar 31, 2020(FY)Dec 31, 2019
Turnover --14.47M----------15.93M--2.96M---------20.77%10.33M----89.47%13.04M
Operating income 14.47M15.93M2.96M-20.77%10.33M89.47%13.04M
Cost of sales ---349K-----------983K---787K--------72.85%-2.6M-----75.39%-9.56M
Operating expenses -349K-983K-787K72.85%-2.6M-75.39%-9.56M
Gross profit 14.12M14.95M2.17M122.46%7.74M143.15%3.48M
Selling expenses ------------15.68%-83.14M-132.52%-63.05M---98.6M---27.12M------------
Administrative expenses 46.94%-38.55M6.63%-125.24M13.59%-72.64M35.31%-134.13M28.41%-84.06M14.12%-207.35M---117.42M-170.17%-241.44M-476.79%-32.79M-301.02%-89.37M
Research and development expenses 51.20%-109.68M3.36%-564.28M23.84%-224.78M4.71%-583.88M-8.70%-295.14M12.04%-612.72M---271.53M-58.74%-696.57M-58.41%-111.44M-61.63%-438.82M
Impairment and provision -------8.92M--------------------------------
-Other impairment is provision -------8.92M--------------------------------
Special items of operating profit 146.61%4.03M-466.01%-12.76M-64.33%1.64M-94.15%3.49M-79.03%4.58M103.02%59.56M--21.86M-47,808.42%-1.97B-8.45%1.44M-57.58%4.14M
Operating profit 56.02%-130.08M9.14%-711.2M32.08%-295.78M8.89%-782.72M-10.47%-435.5M70.41%-859.11M-394.21M-457.66%-2.9B-92.78%-142.79M-84.20%-520.57M
Financing income -43.36%11.49M-34.84%34.74M-27.48%20.29M124.68%53.31M275.64%27.97M538.73%23.73M--7.45M495.35%3.72M-37.77%201K-61.00%624K
Financing cost -1,256.34%-8.98M65.54%-1.04M61.67%-662K90.25%-3.02M91.25%-1.73M77.43%-30.93M---19.73M-3,613.82%-137M-69.28%-970K47.83%-3.69M
Earning before tax 53.81%-127.57M7.50%-677.5M32.52%-276.16M15.45%-732.42M-0.68%-409.25M71.47%-866.31M-406.49M-479.85%-3.04B-93.17%-143.56M-81.77%-523.64M
Tax 14.68%1.28M12.65%2.28M-57.59%1.12M117.17%2.02M-33.32%2.63M-83.95%932K--3.95M551.63%5.81M--1.04M--891K
After-tax profit from continuing operations 54.09%-126.29M7.55%-675.22M32.36%-275.04M15.60%-730.4M-1.01%-406.62M71.44%-865.37M-402.54M-479.73%-3.03B-91.77%-142.52M-81.46%-522.75M
Earning after tax 54.09%-126.29M7.55%-675.22M32.36%-275.04M15.60%-730.4M-1.01%-406.62M71.44%-865.37M-402.54M-479.73%-3.03B-91.77%-142.52M-81.46%-522.75M
Minority profit -20.16%-590K-369.23%-854K50.25%-491K-21.33%-182K40.22%-987K95.59%-150K---1.65M-412.35%-3.4M---552K---664K
Profit attributable to shareholders 54.22%-125.7M7.65%-674.36M32.31%-274.55M15.60%-730.21M-1.18%-405.63M71.42%-865.22M-400.89M-479.81%-3.03B-91.03%-141.97M-81.23%-522.08M
Basic earnings per share 53.70%-0.258.28%-1.3333.33%-0.5417.14%-1.451.22%-0.8185.84%-1.75-0.82-553.97%-12.36-88.89%-0.51-68.75%-1.89
Diluted earnings per share 53.70%-0.258.28%-1.3334.15%-0.5418.08%-1.450.00%-0.8285.68%-1.77-0.82-553.97%-12.36-88.89%-0.51-68.75%-1.89
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-2.21%